The Whole Exome Sequencing Market is expected to experience high growth in Asia, particularly in China and India.
(PRWEB) August 17, 2014
Global whole exome sequencing market has the largest share of services segment since it has a variety of applications in all areas, including diagnostics, drug discovery and development, personalized medicine, and agriculture and animal research. Diagnostics emerged as the largest whole exome sequencing application, primarily because of an increase in the usage of exome sequencing technologies in cancer and rare disease research. The applications of whole exome sequencing (WES) technologies have witnessed growth in recent years, which can be primarily attributed to the availability of advanced systems, as well as the low cost of conducting exome sequencing as compared with that of whole genome sequencing. The technological advancement is evident from the number of improved versions of existing sequencers released in recent years. The major factors driving the growth of this market include its low cost and high speed, increase in applications areas for exome sequencing technologies, global alliances amongst leading research institutes to boost drug discovery, and the entry of new players in the whole-exome sequencing market. However, the high cost of instruments, the need for skilled professionals, and high reliability on grants are hindering the market’s growth.
Complete report is available at http://www.reportsnreports.com/reports/295445-whole-exome-sequencing-market-by-product-systems-kits-library-preparation-target-enrichment-by-services-sequencing-by-technology-sequencing-by-synthesis-by-application-cancer-monogenic-disorders-global-forecast-to-2018.html.
In the years to come, the whole exome sequencing market is expected to experience high growth in Asia, particularly in China and India. These countries will serve as new revenue pockets for whole exome sequencing products and services companies. High growth in these regions can be attributed to growth in the pharmaceutical and biotech industry and crop research, increased funding scenarios and collaborations with established market players. U.S. and Europe are witnessing steady growth owing to new applications in diagnostics, applied markets, and technological advancements in these regions. Rest of the world (RoW) includes regions such as Latin America, Africa, the Middle East, and Pacific countries, which have increased focus on research and gaining funds, thus increasing the potential for whole exome sequencing in these regions. While the global whole exome sequencing products market witnesses low competitive intensity, competition is strong in the services market, with few big firms and many small companies in the fray offering similar services. These companies adopt various strategies (innovations, acquisitions, and geographic expansions) to increase their market shares and establish a strong foothold in the global market.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of and services offered by top players in the whole exome sequencing market. The report analyzes the whole exome sequencing market by products and services.
- Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the whole exome sequencing market.
- Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes markets for various whole exome sequencing technologies and services across geographies.
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the whole exome sequencing market.
- Competitive Assessment: In-depth assessment of market shares, strategies, products and services, distribution networks, and manufacturing capabilities of leading players in the whole exome sequencing market .
Companies like Illumina, Inc., Thermo Fisher Scientific, Inc., Beijing Genomics Institute (Bgi), Macrogen, Inc., Eurofins Genomics, Inc., Agilent Technologies, Inc., Ambry Genetics, Genewiz, Inc., Knome, Inc., Roche Nimblegen, Inc., and Sengenics are profiled in this research available for purchase at http://www.reportsnreports.com/Purchase.aspx?name=295445.
Table of Contents
Whole Exome Sequencing Market by Product (Systems, Kits (Library Preparation, Target Enrichment), by Services (Sequencing), by Technology (Sequencing by Synthesis), by Application (Cancer, Monogenic disorders) - Global Forecast to 2018 Research Report Includes:
1.1 Objectives of the Study
1.2 Report Description
1.3 Markets Covered
1.5 Research Methodology
2 Executive Summary
3 Market Overview
3.2 Market Dynamics
3.3 Market Share Analysis
4 Whole Exome Sequencing Market, By Products and Services
5 Global Whole Exome Sequencing Market, By Technology
5.2 Sequencing By Synthesis (SBS)
5.3 ION Semiconductor Sequencing
5.4 Other Technologies
6 Whole Exome Sequencing Market, By Application
6.3 Drug Discovery and Development
6.4 Personalized Medicine
6.5 Agriculture & Animal Research
6.6 Other Applications
7 Global Wholeexome Sequencing Market, By End User
7.1 End Users
8 Global Whole Exome Sequencing Market, By Geography
8.2 North America
8.5 Rest of the World (ROW)
9 Competitive Landscape
9.2 Agreements, Partnerships, & Collaborations
9.3 New Product Launches
10 Company Profiles
10.1 Illumina, Inc.
10.2 Thermo Fisher Scientific, Inc.
10.3 Beijing Genomics Institute (Bgi)
10.4 Macrogen, Inc.
10.5 Eurofins Genomics, Inc.
10.6 Agilent Technologies, Inc.
10.7 Ambry Genetics
10.8 Genewiz, Inc.
10.9 Knome, Inc.
10.10 Roche Nimblegen, Inc.
Priced at US$ 4650 for a single user PDF license, request a discount on this research at http://www.reportsnreports.com/contacts/Discount.aspx?name=295445.
Browse Similar Reports:
Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2018 is a July 2014 publication of 210 pages. It says growth in the biopharmaceutical market will drive the growth of the cell culture market.
Companies profiled in this report include Becton, Dickinson and Company, Corning, Inc., Eppendorf AG, Lonza Group Ltd., Merck Kgaa, Sartorius AG, Sigma-Aldrich Corporation, Thermo Fisher Scientific, Inc., and Promocell GMBH.
Complete report is available at http://www.reportsnreports.com/reports/291293-cell-culture-market-by-equipment-bioreactor-incubator-centrifuge-by-reagent-media-sera-growth-factors-serum-free-media-by-application-cancer-research-gene-therapy-drug-development-vaccine-production-toxicity-testing-global-forecast-to-2018.html.
Explore more reports on the Biotechnology at http://www.reportsnreports.com/market-research/biotechnology/.
ReportsnReports.com is an online market research reports library of 450,000+ reports and in-depth studies of 5000+ micro markets. We provide reports by 100+ publishers, including MarketsandMarkets (http://www.reportsnreports.com/latest-market-research.aspx).